NERV Competitors & Alternatives
Compare Minerva Neurosciences Inc with similar stocks in the same industry
Biotechnology
NERV
Main Stock$4.81
Tradestie Score
35
Market Cap
$14.69M
Analyst Upside
+114.8%
Top Competitors
241 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$8.24
|
$258.18M | - | 36 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$39.64
|
$256.54M | - | 38 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$13.29
|
$240.89M | - | 38 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$4.71
|
$231.77M | - | 31 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$10.21
|
$227.00M | - | 33 | Compare |
|
CABA
Cabaletta Bio, Inc. Common Stock
|
$3.10
|
$211.28M | - | 29 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$14.33
|
$211.22M | - | 34 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$6.31
|
$202.58M | - | 38 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$16.97
|
$199.71M | - | 43 | Compare |
More NERV Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)
241 stocks in this industry